Skip to content

Edwards Lifesciences IHFM vs FIRE1

Edwards Lifesciences IHFM logo

Edwards Lifesciences IHFM

Global leader in the medical device industry with a patient-focused culture of innovation in heart failure management

99 employees · est. 2007 · Naperville, United States

VS
FIRE1  logo

FIRE1

Our purpose is to help millions of people living with heart failure to get their normal back

63 employees · est. 2014 · Dublin, Ireland

Edwards Lifesciences IHFM is the older company (2007 vs 2014).

Side-by-Side Comparison

Edwards Lifesciences IHFM FIRE1
Founded
2007 older 2014
Headquarters
Naperville, United States Dublin, Ireland
Employees
99 63
Industry
Biotechnology, Health Care, IT Biotechnology, Health Care, Health and Wellness
Funding Stage
Acquired Venture round
Total Funding
$136.65M $72.50M
Funding Rounds
12 4
Services
Remote Monitoring of Heart Data, PA Pressure Data Collection, Vital Sign Data for Medication Optimization, Patient Health Trend Visibility Not tracked yet
Target Customers
Patients with NYHA Class III Heart Failure, Clinicians, Caregivers Not tracked yet
Taxonomy
Digital HealthMedtechHeart Failure TreatmentDisease ManagementHealth MonitoringImplantable Sensor +5 CardiologyHeart FailurePatient OutcomesQuality Of LifeRemote Patient Monitoring
Website
endotronix.com fire1foundry.com
Edwards Lifesciences IHFM logo

About Edwards Lifesciences IHFM

Endotronix, founded in 2007, is a pioneering force at the nexus of Medtech and Digital Health, focused on advancing heart failure care. Their core product, the Cordella solution, leverages pulmonary artery (PA) pressure analytics alongside vital sign data to facilitate proactive management of heart...

FIRE1  logo

About FIRE1

FIRE1 is a biotechnology and healthcare startup founded in 2013 and based in Ireland. The company's mission, as encapsulated in its slogan, is to "help millions of people living with heart failure to get their normal back." They aim to achieve this by improving patient quality of life and outcomes,...

Also comparing in this category

Comparing more than these two?

Get Edwards Lifesciences IHFM, FIRE1 and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Edwards Lifesciences IHFM compare?

A PDF of Edwards Lifesciences IHFM and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Edwards Lifesciences IHFM was founded in 2007, based in Naperville, United States, with 99 employees. Endotronix, founded in 2007, is a pioneering force at the nexus of Medtech and Digital Health, focused on advancing heart failure care. Their core product, the Cordella solution, leverages pulmonary a. FIRE1 was founded in 2014, based in Dublin, Ireland, with 63 employees. FIRE1 is a biotechnology and healthcare startup founded in 2013 and based in Ireland. The company's mission, as encapsulated in its slogan, is to "help millions of people living with heart failure to.
Edwards Lifesciences IHFM has raised $136.65M and FIRE1 $72.50M. Latest stage: Edwards Lifesciences IHFM Acquired, FIRE1 Venture round.
Both work in Biotechnology, Health Care and Medical Devices and list remote patient monitoring among their focus areas.

Compare Edwards Lifesciences IHFM with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Edwards Lifesciences IHFM on 12 Sep 2024, and FIRE1 on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout